First AD

Second AD

Kathryn E. Beckermann, MD, PhD, is an assistant professor in the Department of Medicine of the Division of Hematology and Oncology at the Vanderbilt School of Medicine in Nashville, Tennessee.

Rounding Up Relevant Data in RCC With Drs Beckermann and Rini

Brian I. Rini, MD, FASCO, of Vanderbilt-Ingram Cancer Center, and Katy Beckermann, MD, PhD, of Tennessee Oncology, sit down with Chandler Park, MD, FACP, of Norton Cancer Institute, to discuss the latest abstracts in renal cell carcinoma presented during the 2025 ESMO Congress.

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


OncLive News Network: On Location at ESMO 2025

OncLive News Network®

Vanderbilt-Ingram Cancer Center

Cancer Centers

Partner

Brian I. Rini, MD, FASCO, and Katy Beckermann, MD, PhD, sit down with Chandler Park, MD, FACP, to discuss the latest abstracts in renal cell carcinoma presented during the 2025 ESMO Congress. 